On Aug 23, 2021 Elixiron Immunotherapeutics closed a Series A round and raised $27,000,000 from China Development Industrial Bank (CDIB), DCI Partners, Fubon Financial Holdings, […]
Seed Round – INSEACT
On Aug 23, 2021 INSEACT closed a Seed round and raised $1,300,000 from ADB Ventures, featuring lead investors . About the company: INSEACT is located […]
Series B – Immunitas Therapeutics
On Aug 18, 2021 Immunitas Therapeutics closed a Series B round and raised $58,000,000 from 120 Capital Management, Agent Capital, Alexandria Venture Investments, BrightEdge Fund, […]
Series C – Molcure
On Aug 18, 2021 Molcure closed a Series C round and raised ¥800,000,000 from GMO VenturePartners, JAFCO Group, Japan Post Capital, Nippon Chemiphar, SBI Investment, […]
Series E – Apeel Sciences
On Aug 18, 2021 Apeel Sciences closed a Series E round and raised $250,000,000 from Andreessen Horowitz, Anne Wojcicki, David Barber, Disruptive Technologies, GIC, K3 […]
Series C – Molcure
On Aug 18, 2021 Molcure closed a Series C round and raised ¥800,000,000 from GMO VenturePartners, JAFCO Group, Japan Post Capital, Nippon Chemiphar, SBI Investment, […]
Seed Round – Aether Biomedical
On Aug 11, 2021 Aether Biomedical closed a Seed round and raised $3,600,000 from Chiratae Ventures, Joyance Partners, Story Ventures, Sunfish Partners, featuring lead investors […]
Seed Round – Aether Biomedical
On Aug 11, 2021 Aether Biomedical closed a Seed round and raised $3,600,000 from Chiratae Ventures, Joyance Partners, Story Ventures, Sunfish Partners, featuring lead investors […]
Series A – LQT Therapeutics
On Aug 10, 2021 LQT Therapeutics closed a Series A round and raised $19,000,000 from Alexandria Venture Investments, Amplitude Venture Capital, Amzak Health Investors, Fonds […]
Vividion Therapeutics acquired by Bayer
Aug 5, 2021 Bayer has entered into an agreement to acquire Vividion Therapeutics in a $1,500,000,000 deal. Bayer based at Leverkusen, Nordrhein-Westfalen, Germany. “We exist […]
